DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
02 1FARMHISPANIA GROUP (SUISSE) SA Lugano CH
03 2ARCH PHARMALABS LIMITED Mumbai IN
04 1CIPLA LIMITED Mumbai IN
05 1Eli Lilly And Company Indianapolis US
06 3FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN
07 1FUAN PHARMACEUTICAL GROUP NINGBO TEAM PHARMACEUTICAL CO., LTD. Ningbo CN
08 2HETERO LABS LIMITED Hyderabad IN
09 2INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
10 1JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. Lianyungang City CN
11 1LAURUS LABS LIMITED Hyderabad IN
12 1LAURUS LABS PRIVATE LIMITED Hyderabad IN
13 1RAVI BIOLIFE PRIVATE LTD. Mumbai IN
14 1SCINOPHARM TAIWAN, LTD. Shan-Hua TW
15 2SHILPA PHARMA LIFESCIENCES LIMITED Raichur IN
16 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
17 1TAPI NL B.V. Amsterdam NL
18 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
19 1Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN
Reset all filters
01 16Gemcitabine hydrochloride
02 1Gemcitabine hydrochloride, Alternate Process-2
03 1Gemcitabine hydrochloride, Alternate process
04 1Gemcitabine hydrochloride, GA process
05 1Gemcitabine hydrochloride, Process III
06 2Gemcitabine hydrochloride, Process-2
07 1Gemcitabine hydrochloride, Product code: GAI
08 1Gemcitabine hydrochloride, Product code: GMI
09 1Gemcitabine hydrochloride, alpha-Mesylribose process
Reset all filters
01 3China
02 16India
03 1Israel
04 1Spain
05 1Taiwan
06 1U.S.A
07 2Blank
Reset all filters
01 1Expired
02 20Valid
03 2Withdrawn by EDQM Failure to CEP procedure
04 2Withdrawn by Holder
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2007-075 - Rev 06
Status : Valid
Issue Date : 2021-06-18
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2011-032 - Rev 01
Status : Valid
Issue Date : 2017-09-27
Type : Chemical
Substance Number : 2306
Certificate Number : CEP 2008-131 - Rev 05
Status : Valid
Issue Date : 2024-11-04
Type : Chemical
Substance Number : 2306
Gemcitabine Hydrochloride, Alternate Process-2
Certificate Number : CEP 2023-271 - Rev 00
Status : Valid
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2009-042 - Rev 01
Status : Valid
Issue Date : 2015-10-16
Type : Chemical
Substance Number : 2306
Certificate Number : CEP 2017-076 - Rev 01
Status : Valid
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2009-089 - Rev 02
Status : Valid
Issue Date : 2022-07-13
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2009-026 - Rev 02
Status : Valid
Issue Date : 2023-01-24
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2008-161 - Rev 02
Status : Valid
Issue Date : 2021-12-20
Type : Chemical
Substance Number : 2306
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2023-229 - Rev 00
Status : Valid
Issue Date : 2024-08-05
Type : Chemical
Substance Number : 2306
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
91
PharmaCompass offers a list of Gemcitabine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gemcitabine manufacturer or Gemcitabine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gemcitabine manufacturer or Gemcitabine supplier.
PharmaCompass also assists you with knowing the Gemcitabine API Price utilized in the formulation of products. Gemcitabine API Price is not always fixed or binding as the Gemcitabine Price is obtained through a variety of data sources. The Gemcitabine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gemcitabine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gemcitabine HCl, including repackagers and relabelers. The FDA regulates Gemcitabine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gemcitabine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gemcitabine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gemcitabine HCl supplier is an individual or a company that provides Gemcitabine HCl active pharmaceutical ingredient (API) or Gemcitabine HCl finished formulations upon request. The Gemcitabine HCl suppliers may include Gemcitabine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Gemcitabine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gemcitabine HCl CEP of the European Pharmacopoeia monograph is often referred to as a Gemcitabine HCl Certificate of Suitability (COS). The purpose of a Gemcitabine HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gemcitabine HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gemcitabine HCl to their clients by showing that a Gemcitabine HCl CEP has been issued for it. The manufacturer submits a Gemcitabine HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gemcitabine HCl CEP holder for the record. Additionally, the data presented in the Gemcitabine HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gemcitabine HCl DMF.
A Gemcitabine HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gemcitabine HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gemcitabine HCl suppliers with CEP (COS) on PharmaCompass.
We have 16 companies offering Gemcitabine HCl
Get in contact with the supplier of your choice: